WHO ICTRP trial
Home based cardioversion, feasible and safe?
NL-OMON26484 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON26484 |
|---|---|
| Public title | Home based cardioversion, feasible and safe? |
| Scientific title | RegionAl Home CardiovErsion study of atrial fibrillation. Pilot study on feasibility and safety. |
| Primary sponsor | Academisch ziekenhuis Maastricht (azM) |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Conditions | Symptomatic recurrent persistent Atrial fibrillation Electro cardiversion Home based cardiac intervention Emergency Care Practitioners In Dutch: Recidief symptomatisch persisterend atriumfibrilleren Electrische cardioversie Cardiale… |
| Interventions | Race-6 is an observational pilot study during 6 weeks, without a control group. The intervention deployed is a standard electrical cardioversion performed in the home environment of the patients. In detail: we will investigate the… |
| Registration date | Jul 16, 2013 |
| Target size | 30 |
| Secondary IDs | NL3908;NTR4078;NL 42344.068.12;ISRCTN wordt niet meer aangevraagd. |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: